SCHEMBL31546013

SCHEMBL31546013

CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(O)CC2C(CC)=C(C)C

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545115 0.79 CNR2 (0.46) —
SCHEMBL31545137 0.78 CNR1 (0.45) —
SCHEMBL31545328 0.78 CNR1 (0.45) —
SCHEMBL31544917 0.70 CNR2 (0.38) —
SCHEMBL31545360 0.70 CNR1 (0.37) —
SCHEMBL11830751 0.70 OPRM1 (0.39) KDR
SCHEMBL31544899 0.68 CNR2 (0.44) —
SCHEMBL11728967 0.67 CNR2 (0.59) KDR
SCHEMBL11634629 0.67 CNR2 (0.59) KDR
SCHEMBL11312166 0.66 KDR (0.38) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback